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Abstract
Objective: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a new method 
for the diagnosis and staging of mediastinal lymph nodes. The objective of this study was to evaluate the 
preliminary results obtained with EBUS-TBNA in the diagnosis of lesions and mediastinal lymph node staging. 
Methods: We evaluated patients with tumors or mediastinal adenopathy, diagnosed with or suspected of having 
lung cancer. The procedures were performed with the patients under sedation or under general anesthesia. 
Material was collected by EBUS-TBNA, after which it was prepared on slides, fixed in either absolute alcohol 
(for cytology) or formalin (for cell-block analysis). Results: We included 50 patients (30 males). The mean age 
was 58.3 ± 13.5 years. We performed 201 biopsies of 81 lymph nodes or mediastinal masses (mean of 2.5 
punctures/biopsy). The quantity of material was considered appropriate for cytology in 37 patients (74%), 21 
(57%) of whom were thus diagnosed with malignancy. Of the remaining 16 patients, 1 was diagnosed with 
tuberculosis, 6 entered clinical follow-up, and 9 underwent further investigation (2 diagnosed with neoplasm—
false-negative results). The yield was higher when the procedure was performed for diagnostic purposes, as 
well as being higher in patients with lesions in multiple stations and in biopsies involving the subcarinal lymph 
node station. One patient had endobronchial bleeding, which was resolved with local measures. There were no 
deaths among the patients evaluated. Conclusions: This preliminary experience shows that EBUS-TBNA is a 
safe procedure. Our diagnostic yield, although lower than that reported in the literature, was consistent with 
the learning curve for the method.
Keywords: Ultrasonography, interventional; Biopsy, fine-needle; Neoplasm staging; Lung neoplasms; 
Bronchoscopy.
Resumo
Objetivo: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA, punção aspirativa 
por agulha guiada por ultrassom endobrônquico) é um método novo em diagnóstico e estadiamento linfonodal 
mediastinal. O objetivo do estudo foi avaliar os resultados preliminares obtidos com EBUS-TBNA no diagnóstico 
de lesões e no estadiamento linfonodal mediastinal. Métodos: Foram avaliados pacientes com tumores ou 
adenopatias mediastinais e com diagnóstico ou suspeita de câncer de pulmão. Os procedimentos foram realizados 
com os pacientes sob sedação ou anestesia geral. O material coletado foi preparado em lâminas fixadas em 
álcool absoluto para citologia e em formol para bloco de células. Resultados: Foram incluídos 50 pacientes 
(30 do sexo masculino), com média de idade de 58,3 ± 13,5 anos. Foram realizadas 201 punções em 81 
linfonodos ou massas mediastinais (média de 2,5 punções). O material obtido foi considerado adequado para 
análise citológica em 37 pacientes (74%), dos quais 21 (57%) foram diagnosticados com malignidade. Nos 16 
pacientes remanescentes, 1 teve diagnóstico de tuberculose, 6 tiveram seguimento clínico, e 9 foram submetidos 
a investigação adicional (2 diagnosticados com neoplasia — resultados falso-negativos). O rendimento do exame 
foi maior nos procedimentos com objetivo diagnóstico, em pacientes com lesões em múltiplas estações, e nas 
punções da estação linfonodal subcarinal. Um paciente apresentou sangramento endobrônquico resolvido com 
medidas locais. Não houve mortalidade na série. Conclusões: Esta experiência preliminar confirmou que o EBUS-
TBNA é procedimento seguro, e que o nosso rendimento diagnóstico, inferior ao da literatura, foi compatível 
com a curva de aprendizado do método.
Descritores: Ultrassonografia de intervenção; Biópsia por agulha fina; Estadiamento de neoplasias; 
Neoplasias pulmonares; Broncoscopia.
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Análise de Projeto de Pesquisa—CAPPesq, Ethics 
Committee for the Analysis of Research Projects—
Protocol no. 0923/08).
Conventional bronchoscopy was performed 
previously, and patients with endobronchial lesions 
were excluded from the study. The EBUS-TBNA 
procedure was performed with the patient under 
sedation or under general anesthesia, together 
with noninvasive monitoring of cardiac function 
and blood pressure, as well as oximetry. The 
EBUS device (model BF-UC180F; Olympus Corp., 
Tokyo, Japan) was introduced orally, through a 
laryngeal mask or an intubation tube.
After ultrasound identification of the 
lymph nodes or masses, an aspiration needle 
(model NA-201SX-402; Olympus Corp.) was 
introduced into the working channel of the 
device. Real-time ultrasound-guided TBNA was 
performed through the tracheobronchial wall. The 
material collected was prepared on slides, fixed 
in either absolute alcohol (for cytology smear 
testing) or formalin (for paraffin-embedded cell-
block analysis). The material was separated on 
the basis of the lymph node station punctured 
(2R, 2L, 4R, 4L, 7, 10R, 10L, 11R, and 11L). 
Tissue fragments that might have been collected 
were fixed in formaldehyde. In some cases, 
immunohistochemical analysis was performed 
to complement the study.
The cytological specimens obtained were 
classified as “appropriate” material when there 
were lymphocytes or pathological cells, or both, 
on the slide. An excess of red blood cells on the 
slide, as well as technical errors in sampling or 
processing the material, can generate samples 
considered “inappropriate” for cytology.
In the cancer cases, the presence of malignant 
cells defined the diagnosis as “positive”. The 
sample that was appropriate and normal, or 
benign, was classified as “negative” diagnosis. If 
the diagnostic EBUS-TBNA sample was normal, 
but it was classified as malignant after the 
confirmatory procedure, the result was classified 
as “false-negative”. If the EBUS-TBNA sample 
was malignant, but it was considered normal 
after the confirmatory procedure, the result was 
defined as “false-positive”.
Possible adverse events were recorded. 
Confirmatory procedures, such as mediastinoscopic 
biopsy or video-assisted thoracoscopic biopsy, were 
performed as needed for further investigation.
Introduction
Invasive diagnosis of mediastinal lesions 
is fundamental, particularly in the presence 
of mediastinal lymphadenopathy or in the 
staging of lung cancer. Despite the advances 
in imaging methods, tissue samples are essential 
for diagnostic confirmation and treatment 
planning. Mediastinoscopy is considered the 
standard invasive method for the evaluation of 
mediastinal masses and lymph nodes.(1)
Recently, less invasive methods have emerged as 
an alternative for collecting material for cytology. 
Among these methods, endobronchial ultrasound 
(EBUS), which was developed in the past decade, 
stands out as an outpatient method and allows 
access not only to paratracheal stations but also 
to hilar stations, being able to detect and collect 
material from lymph nodes smaller than 1 cm.(2)
Internationally, EBUS with transbronchial 
needle aspiration (TBNA) has been routinely 
used in the staging of lung cancer. Studies 
have shown that EBUS-TBNA has a sensitivity 
of approximately 93%, a specificity of 100%, 
and a negative predictive value of 96% in the 
evaluation of mediastinal and hilar lymph nodes 
in the staging of lung cancer.(3,4)
The objective of the present study was to 
describe the first Brazilian experience with EBUS-
TBNA, the results obtained, and the learning 
curve for the method in the diagnosis of masses 
and adenopathies, as well as in the mediastinal 
staging of lung cancer.
Methods
This was a prospective cohort study conducted 
at the Heart Institute of the University of São Paulo 
School of Medicine Hospital das Clínicas and at 
the São Paulo Cancer Institute, both located in 
the city of São Paulo, Brazil, between February of 
2010 and February of 2011. We included patients 
treated at the thoracic surgery and pulmonology 
outpatient clinics who had lung cancer and 
(mediastinal or hilar) lymph node enlargement 
(greater than 10 mm) or (mediastinal or hilar) 
masses requiring confirmation by CT findings. 
We excluded patients who were deemed clinically 
unfit for respiratory endoscopy, patients with 
endobronchial lesions, and those who did not 
give written informed consent. The study was 
approved by the medical ethics committees of 
the two institutions (Comissão de Ética para a 
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In 1 patient, there was bleeding requiring 
the discontinuation of the procedure, and the 
bleeding was controlled with cold saline and 
with adrenaline solution. The patient’s course 
was satisfactory, without hematomas or other 
complications.
We performed 201 biopsies of 81 lymph nodes, 
totaling 2.5 punctures/biopsies per lymph node. 
Figure 1 summarizes the results obtained. The 
samples considered inappropriate for cytology 
had a large proportion of red blood cells or a 
sparse representation of lymphoid cells, or both.
As can be seen in Figure 1, among the patients 
in whom the material was considered appropriate 
for cytology, 21 had neoplastic disease and 16 
had benign disease. The cytological diagnoses 
were as follows: adenocarcinoma, in 10 cases; 
epidermoid carcinoma, in 5; small cell cancer, in 3; 
undifferentiated neoplasm, in 2; and lymphoma, 
in 1. With regard to benign disease, the diagnoses 
were reactive lymphadenitis, in 15 cases, and 
granulomatous lymphadenitis, in 1.
Among the patients diagnosed with benign 
disease, 1 was diagnosed with tuberculosis and 9 
underwent further investigation, which identified 
malignant disease (lymphoma and lung cancer) 
in 2, thereby constituting false-negative results 
of the method. The remaining 6 patients did not 
undergo additional procedures and remained 
under clinical follow-up.
Numerical variables are expressed as means 
and standard deviations, and categorical variables 
are expressed as frequencies and proportions.
Results
In the present study, we included 50 patients 
submitted to EBUS-TBNA. The characteristics of 
the population studied are described in Table 1.
Table 1 - Characteristics of the population studied.a
Characteristic Result
n = 50
Gender, M/F 30/20
Age, yearsb 58.3 ± 13.5
Previous diagnosis of neoplasmc 25 (50)
Pulmonary 12
Purpose of the procedure  
Diagnosis 29
Staging 12
Diagnosis and staging 9
Location of the lesiond
Hilum 10
Mediastinum (single station) 13
Multiple stations 21
aValues expressed as n, except where otherwise indicated. 
bValue expressed as mean ± SD. cValue expressed as n (%). 
dThe location of the lesion was not accurately determined 
in 6 patients.
Figure 1 - Results for the patients submitted to endobronchial ultrasound transbronchial needle aspiration 
(EBUS-TBNA). *For cytology. **The suspicious lymph nodes were not addressed, and the final diagnosis was 
established otherwise.
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of the method. In Brazil, EBUS only became 
available in 2010.
The discussion of our results, in comparison 
with literature data, which are generally produced 
by long-established centers, shows significant 
differences. In order to explain the reasons 
for these differences, we chose to perform an 
analysis by topic areas. This discussion reveals 
the difficulties faced during the development of 
the study, which corresponded to the period of 
implementation of the procedure, since it was 
a new technique, which, to our knowledge, had 
not been used in Brazil before.
The initial reports on the use of EBUS indicated 
that the procedure should be performed with the 
patient under general anesthesia. Although, in 
some of our cases, the procedure was performed 
with the patient under sedation, in most of them, 
we used general anesthesia, which allows the 
examining physician to perform a more accurate 
staging, especially when there is no evidence 
of mediastinal lymph node enlargement on 
CT, or when one begins to use the method. 
However, this is not the rule. Many centers in 
the world perform the procedure with the patient 
under sedation in order to reduce costs. One 
group of authors evaluated, with the use of 
questionnaires, the degree of satisfaction of 41 
patients submitted to EBUS under sedation. The 
authors concluded that EBUS can be performed 
safely under conscious sedation, with a high 
degree of patient satisfaction.(5)
One difficulty in implementing the procedure 
is related to working together with the surgical 
Tables 2 and 3 show, by purpose of the 
procedure and by location of the suspicious 
lesion, the proportion of cases whose samples 
contained appropriate material for analysis. The 
yield seemed to be higher when the procedure 
was performed for diagnostic purposes than 
when it was performed for cancer staging. The 
yield was also higher in patients with lesions in 
multiple stations. Supporting this hypothesis is 
the fact that, in all 7 patients with mediastinal 
disease in multiple stations and with radiological 
suspicion of lung cancer, all of whom underwent 
the procedure for diagnostic and staging purposes, 
the definitive diagnosis was established by EBUS-
TBNA. In contrast, only 1 patient diagnosed with 
ovarian cancer and presenting with a suspicious 
hilar lesion underwent EBUS-TBNA for staging 
purposes, and, in this patient, the sample was 
considered inappropriate for cytology.
Of the 81 lymph nodes punctured, most were 
located in the paratracheal stations, as shown in 
Table 4. The analysis of the yield of the punctures/
biopsies in relation to the location of the lymph 
nodes punctured revealed that the subcarinal 
station exhibited the highest yield, whereas the 
hilar stations exhibited the lowest yield.
Discussion
A review of the first studies on EBUS showed 
that a few centers were responsible for much of 
that scientific output. Even after encouraging initial 
results were published by those groups, the high 
costs of the equipment and accessories and the 
need for training limited the rapid dissemination 
Table 2 - Results by purpose of the procedure for each patient.a
Purpose of the procedureb Patients in whom the material 
was considered appropriate
Result
Malignant disease False-negative
Diagnosis (n = 29) 24 (69.6) 12 (50) 2 (16.6)
Staging (n = 12) 5 (41.6) 2 (40) 0 (0.0)
Diagnosis and staging (n = 9) 8 (88.8) 7 (87.5) 0 (0.0)
aValues expressed as n (%). bDiagnosis: cases with mediastinal lesions with no previous diagnosis; staging: cases with an 
established diagnosis of lung cancer requiring mediastinal staging; and diagnosis and staging: cases of radiologically 
suspected lung cancer with no previous diagnosis.
Table 3 - Results by location of the lesion for each patient.a
Location of the lesion Patients in whom the material 
was considered appropriate
Result
Malignant disease False-negative
Hilum (n = 10) 5 (50.0) 3 (60.0) 0 (0.0)
Mediastinum (single station; n = 13) 10 (76.9) 5 (50.0) 1 (20.0)
Mediastinum (multiple stations; n = 21) 18 (85.7) 11 (61.1) 0 (0.0)
aValues expressed as n (%).
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slides determine how the preparation should 
be performed.
Considering that the samples collected at 
each biopsy/puncture should be distributed on 
four or more slides, which should be rapidly 
placed in 70% alcohol to avoid artifacts, it is 
clear that there is need for trained and qualified 
in-room personnel to perform the procedures.(10) 
Inappropriate slide preparation, which certainly 
occurred at the beginning of our experience, 
probably contributed to the large number of tests 
whose results were classified as “inappropriate 
sample” or inconclusive.
Studies in the literature suggest that a 
pathologist should be present in the room 
where EBUS is being performed, in an attempt 
to minimize the number of inconclusive tests. 
The international literature refers to this working 
structure as rapid on site cytology.(11) Although the 
advantages of this scheme are indisputable because 
it facilitates rapid clinical decision-making, 
few centers can afford to maintain an in-room 
pathologist who has time to wait for the test. 
This scheme is justifiable in a scenario where 
cases with nondiagnostic EBUS results are further 
investigated via mediastinoscopy or video-assisted 
thoracoscopy.
Considering that passing the needle, puncturing 
the lymph nodes, and preparing the slides are time-
consuming procedures, it is clear that the number 
of aspirations per lymph node exponentially 
increases the duration of the procedure.
To determine the optimal number of aspirations 
per lymph node needed to obtain a higher 
diagnostic yield, one group of authors reported 
having performed four aspirations on each of the 
163 lymph nodes studied in 102 patients with 
lung cancer. Those authors obtained 90.1% of 
appropriate samples in the first aspiration, reaching 
100% in the third aspiration. Their conclusion was 
that maximum diagnostic values were achieved 
in three aspirations.(12) In the present study, we 
performed 2.5 punctures/biopsies per lymph 
node. Our impression is that, in the learning 
curve, the number of punctures/biopsies per 
lymph node should have been higher in order 
to increase the diagnostic yield of the method. 
The technical difficulty in accessing the lymph 
nodes, which was a result of our learning curve, 
explains the fact that, in some situations, fewer 
than 3 aspirations were performed.
pathology section. Although there is the possibility 
of occasionally collecting (core) fragments of the 
lesion, the method is essentially cytological rather 
than histological. Unless the fellow pathologists 
are used to cytological methods, which is not 
always current practice in Brazil, this requires a 
period of adaptation or even a learning curve.
Another factor involves the diagnostic criteria. 
The presence of lymphocytes on the slides from 
mediastinal aspirates is an essential criterion for 
determining whether a specimen is appropriate. 
One group of authors demonstrated that the 
predictive value of a negative result was 78% 
and 36%, respectively, for a “non-malignant” 
aspirate that contained lymphocytes and for a 
“non-malignant” aspirate that did not contain 
lymphocytes (p ≤ 0.005).(6)
It is recommended that the samples that do not 
have lymphocytes be classified as “inappropriate”, 
being thus differentiated from inconclusive 
samples. The literature shows that the number 
of nondiagnostic samples ranges from 4% to 
23%.(7,8)
Even experienced centers show relatively high 
rates of inappropriate samples. One group of 
authors reported that, of 131 cases of mediastinal 
lymph node sampling performed at the Johns 
Hopkins Hospital, 7 (5.3%) had samples that 
were considered inappropriate.(9) In the present 
study, the rate of inappropriate samples was 
25%, which is similar to the rates reported in the 
literature for initial experiences. Contributing to 
that is the fact that the biopsies involved hilar 
lymph node stations, which had a higher rate of 
“inappropriate” samples when compared with 
the biopsies involving the subcarinal station, 
which is more easily accessed.
Performing EBUS involves an important point: 
the preparation of smears on slides. Although 
there are descriptions, it is recommended that 
the pathologist responsible for reading the 
Table 4 - Frequency and proportion of patients in 
whom the material was considered appropriate by 
lymph node station evaluated.a
Lymph node station Patients in whom the 
material was considered 
appropriate
Paratracheal (n = 36) 22 (61.1)
Subcarinal (n = 26) 17 (65.3)
Hilar (n = 19) 8 (42.1)
aValues expressed as n (%).
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nodes. The authors reported that EBUS had a 
sensitivity of 89%, a specificity of 100%, an 
accuracy of 92.9%, a positive predictive value 
of 100%, and a negative predictive value of 
83.5%. In our view, those authors provided the 
most accurate figures for EBUS-TBNA in the 
literature.(16)
Another point to be considered is the role of 
mediastinoscopy, which has long been considered 
the gold standard in mediastinal staging. 
Consequently, there is a tendency to compare 
mediastinoscopy results with EBUS results. The 
advantage of using EBUS over mediastinoscopy is 
that the former allows access to a larger number 
of mediastinal lymph node stations than does the 
latter, as reported in one study (a diagnostic rate 
of 87.5% in stations 10 and 11).(17) However, we 
must consider that, although these stations are 
relevant for obtaining a more accurate staging, 
they have no impact on the decision-making 
process regarding surgical treatment.(17) Another 
argument that has been made in favor of EBUS 
is that it is less invasive than is mediastinoscopy, 
which, despite a complication rate of less than 
1%, can cause severe complications.(18,19)
It has also been emphasized that, in cases of 
reassessment of the mediastinum after previous 
mediastinoscopy, surgical lymph node drainage, 
or neoadjuvant therapy, EBUS is safer than a 
second mediastinoscopy because of the fibrosis 
following mediastinoscopy. However, no studies 
have assessed the accuracy and safety of EBUS 
in such cases.
Another potential advantage of EBUS is the 
possibility of sampling mediastinal lymph nodes 
without the need for general anesthesia, because 
it has been demonstrated that the diagnostic 
accuracy of EBUS with or without the use of 
general anesthesia is similar.(13)
A recent study evaluated whether EBUS-TBNA 
is as accurate as mediastinoscopy in the staging 
of lung cancer cases. The authors of the study(20) 
stated that, with larger lymph nodes, the sensitivity 
of EBUS was similar to that of mediastinoscopy, 
although, with normal-sized lymph nodes, the 
former was lower than the latter. The rate of false-
negative EBUS results seemed higher than that 
of false-negative mediastinoscopy results, and, 
therefore, the non-malignant results obtained by 
EBUS could be unreliable. Those authors also cited 
two studies, considered somewhat inconsistent, 
that examined costs and identified that EBUS 
In the case of a patient with a highly 
vascularized peribronchial mass, it was necessary 
to discontinue the procedure due to bleeding. 
Complications resulting from EBUS-TBNA are 
rare. Contributing to that is the fact that the 
biopsies/punctures are performed with a fine 
needle (22G). In addition, the EBUS device is 
equipped with a Doppler mode, which allows the 
identification of vascular structures, minimizing 
the risk of bleeding. The literature reports more 
than one thousand EBUS procedures without 
the occurrence of significant complications.(13,14)
There are aspects related to the published 
literature on EBUS that should be highlighted. 
Because the method is relatively new and the 
equipment is sophisticated and costly, until 
recently, only a few centers around the world were 
responsible for most of the published literature. 
Therefore, it is possible that the excellent results 
were obtained in centers with the best-trained 
professionals and the best equipment.
In most published studies on the use of 
EBUS-TBNA in the staging of lung cancer, there 
was no standard for monitoring false-negative 
results. In those studies, negative EBUS results for 
malignancy were confirmed by mediastinoscopy, 
video-assisted thoracoscopy, or thoracoscopy 
in some cases. However, there were cases in 
which the presumed confirmation of the result 
was based only on patient clinical follow-up, 
a method that is hardly appropriate for this 
confirmation.(15)
In the present study, we had 6 cases in which, 
for various reasons, it was not possible to perform 
ancillary procedures, and those patients remained 
under clinical follow-up as a way to confirm the 
EBUS results obtained. This type of situation, 
which is independent of the will of the investigator, 
might distort the result, especially in cases of 
false-negative results. One group of authors used 
a methodology that minimized the possibility of 
false-negative results in a study involving 226 
lung cancer patients who underwent EBUS for 
mediastinal staging. Of those 226 patients, 97 
had negative EBUS results and were referred for 
mediastinal dissection by Transcervical Extended 
Mediastinal LymphAdenectomy, which revealed 
16 patients (7.1% of those 226) with lymph 
nodes positive for malignancy. All patients whose 
lymph nodes tested negative were then submitted 
to thoracotomy and mediastinal lymph node 
dissection, which revealed no residual lymph 
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which the authors describe their initial experience 
with the method.
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